← FDA DRUG APPROVALS

FDA ANDA · ANDA075095

ETHAMBUTOL HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA075095
TYPE
ANDA
ORIGINAL APPROVAL
1999-11-30
LATEST ACTION
2012-01-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ETHAMBUTOL HYDROCHLORIDEPrescription
ETHAMBUTOL HYDROCHLORIDE 400MG · TABLET · ORAL
ETHAMBUTOL HYDROCHLORIDEPrescription
ETHAMBUTOL HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2012-01-27Labeling · Supplement 6AP
2006-08-22Labeling · Supplement 5AP
2002-02-01Manufacturing (CMC) · Supplement 1AP
2002-02-01Manufacturing (CMC) · Supplement 2AP
1999-11-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →